Literature DB >> 17107369

Hybrid treatment for complex aortic problems combining surgery and stenting in the integrated operating theater.

Martin Brueck1, Martin C Heidt, Michael Szente-Varga, Dirk Bandorski, Wilfried Kramer, Paul R Vogt.   

Abstract

OBJECTIVES: Conventional surgical treatment of complex aortic pathologies involving several thoracoabdominal aortic segments necessitates extended incisions or subsequent surgeries, resulting in significant mortality and morbidity rates. The combination of surgery and simultaneous stenting in the operating theater may reduce the surgical trauma.
METHODS: A total of nine patients (62 +/- 10 years, range 44-70) underwent a combined surgical and endovascular treatment of thoracic or thoracoabdominal aortic aneurysms or chronic dissection. Five patients were treated with viscero-renal artery translocation followed by transfemoral stenting of the entire thoracoabdominal aorta. Two patients underwent debranching of the supraaortic vessels followed by immediate transfemoral stenting of the aortic arch, and two patients with a history of an ascending aortic aneurysm repair were treated with open surgical debranching of the supraaortic trunks and repair of the ascending aorta and aortic arch with elephant trunk technique. Preoperatively, magnetic resonance imaging was used to check supraaortic and intracranial vessels as well as the completeness of the Circle of Willisi prior to arch stenting and/or supraaortic vessel surgery. Cerebrospinal fluid drainage and induced mild hypertension have been used for one-step thoracoabdominal aortic stenting.
RESULTS: Thirty-day mortality rate and incidence of paraplegia was 0%. There was a single reversible perioperative stroke after aortic arch stenting. One patient required temporary renal replacement therapy using continuous arterio-venous hemofiltration. There was one early reoperation at the superior mesenteric artery after viscero-renal translocation. Four type I endoleaks occurred in three patients requiring two interventions. All patients have been discharged to home.
CONCLUSION: The innovative combination of simultaneous conventional surgery and stenting reduces the operative burden for patients with complex aortic pathologies involving several segments of the thoracic and thoracoabdominal aorta. Arch debranching and viscero-renal artery translocation may avoid the use of thoracoabdominal incisions, cardiopulmonary bypass techniques, deep hypothermia, and circulatory arrest.

Entities:  

Mesh:

Year:  2006        PMID: 17107369     DOI: 10.1111/j.1540-8183.2006.00208.x

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  5 in total

1.  Hybrid treatment of isolated aortic arch aneurysms.

Authors:  D Laganà; G Carrafiello; D Lumia; A Ianniello; F Fontana; M Mangini; P Castelli; C Fugazzola
Journal:  Radiol Med       Date:  2009-09-22       Impact factor: 3.469

2.  Overdrive pacing for endovascular repair of an aortic arch aneurysm.

Authors:  Sherif S Zaky; Theodore Marks
Journal:  J Anesth       Date:  2009-11-18       Impact factor: 2.078

3.  Endovascular treatment of complex diseases of the thoracic aorta-10 years single centre experience.

Authors:  Piotr Buczkowski; Mateusz Puślecki; Natalia Majewska; Tomasz Urbanowicz; Marcin Misterski; Robert Juszkat; Jerzy Kulesza; Bartosz Żabicki; Sebastian Stefaniak; Marcin Ligowski; Lukasz Szarpak; Marek Jemielity; Eva Rivas; Kurt Ruetzler; Bartłomiej Perek
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

4.  Endovascular treatment of late thoracic aortic aneurysms after surgical repair of congenital aortic coarctation in childhood.

Authors:  Robert Juszkat; Bartlomiej Perek; Bartosz Zabicki; Olga Trojnarska; Marek Jemielity; Ryszard Staniszewski; Wiesław Smoczyk; Fryderyk Pukacki
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

5.  Clinical features and risk factors of postoperative in-hospital mortality following surgical repair of Stanford type A acute aortic dissection.

Authors:  Chen Ke; Hao Wu; Min Xi; Wei Shi; Qihong Huang; Guirong Lu
Journal:  BMC Cardiovasc Disord       Date:  2021-08-12       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.